NCT07765251

Brief Summary

Gum disease (gingivitis and periodontitis) is a common inflammatory condition affecting the tissues that support the teeth. Smoking is known to make gum disease worse and to affect blood vessel health in the gums. This study looks at two proteins, KLF2 and FBXW7, which are involved in blood vessel formation, to understand their role in gum disease and whether smoking changes their levels. Researchers measured these proteins, along with two other markers of inflammation and blood vessel activity (VEGF and NF-κB), in fluid collected from around the teeth and in saliva from healthy adults who were either smokers or non-smokers, with healthy gums, gingivitis, or periodontitis. The goal is to better understand how smoking and gum disease affect blood vessel-related proteins in the mouth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

August 11, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
Last Updated

August 14, 2026

Status Verified

August 1, 2026

Enrollment Period

7 months

First QC Date

August 11, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

periodontitisgingivitissmokingangiogenesis

Outcome Measures

Primary Outcomes (1)

  • GCF and Salivary VEGF, NF-κB, KLF2, and FBXW7 Protein Levels

    Total amounts and concentrations of VEGF, NF-κB, KLF2, and FBXW7 were measured by ELISA in gingival crevicular fluid (GCF) and unstimulated whole saliva samples, and compared across participants with periodontal health, gingivitis, and periodontitis, in both smokers and non-smokers.

    March to September 2024

Study Arms (6)

Group H

periodontally healthy and non smokers

Group G

gingivitis and non-smokers

Group P

periodontitis and non-smokers

Group S-H

periodontally healthy and non smokers

Group S-G

gingivitis and smokers

Group S-P

periodontitis and non-smokers

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18 to 65 years attending the periodontology clinic were enrolled and classified into 6 groups based on clinical periodontal parameters and smoking status according to the 2017 World Workshop classification: periodontal health, gingivitis, and periodontitis (Stage III Grade B). Exclusion criteria included any systemic disease, regular medication use, pregnancy or lactation, periodontal treatment within the past 6 months, antibiotic use within the past 6 months, and presence of prosthetic restorations on the teeth to be sampled. A total of 114 participants (19 per group; 56 males, 58 females) were included.

You may qualify if:

  • presence of ≥ 20 teeth in the mouth
  • probing pocket depth (PPD) ≤ 3 mm
  • the percentage of bleeding sites for the whole mouth \< 10%,
  • on radiographic examination, a distance of ≤ 3 mm between the cemento-enamel junction and the alveolar bone crest in 95% of all teeth.
  • presence of ≥ 20 teeth in the mouth
  • PPD ≤ 3 mm,
  • % of bleeding sites for the whole mouth ≥ 10%,
  • on radiographic examination, a distance of ≤ 3 mm between the cemento-enamel junction and the alveolar bone crest in 95% of all teeth.
  • presence of ≥ 15 teeth in the mouth
  • more than 30% of teeth affected by periodontal disease
  • affected teeth exhibiting probing depths of 6 mm or more
  • clinical attachment loss (CAL) of ≥ 5 mm,
  • vertical bone loss of 3 mm or more
  • class 2 or 3 furcation involvement
  • radiographic evidence of alveolar bone loss extending to the middle third and beyond (33%) in the relevant teeth

You may not qualify if:

  • presence of any systemic disease
  • regular use of any medication
  • pregnancy or lactation
  • periodontal treatment within the last 6 months
  • antibiotic use within the last 6 months
  • the presence of prosthetic restorations on the teeth to be sampled

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University, Faculty of Dentistry, Deparment of Periodontology

Malatya, 44100, Turkey (Türkiye)

Location

Related Publications (4)

  • Afacan B, Ozturk VO, Pasali C, Bozkurt E, Kose T, Emingil G. Gingival crevicular fluid and salivary HIF-1alpha, VEGF, and TNF-alpha levels in periodontal health and disease. J Periodontol. 2019 Jul;90(7):788-797. doi: 10.1002/JPER.18-0412. Epub 2018 Dec 11.

    PMID: 30536725BACKGROUND
  • Leite FRM, Nascimento GG, Scheutz F, Lopez R. Effect of Smoking on Periodontitis: A Systematic Review and Meta-regression. Am J Prev Med. 2018 Jun;54(6):831-841. doi: 10.1016/j.amepre.2018.02.014. Epub 2018 Apr 12.

    PMID: 29656920BACKGROUND
  • Kawanami D, Mahabeleshwar GH, Lin Z, Atkins GB, Hamik A, Haldar SM, Maemura K, Lamanna JC, Jain MK. Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium. J Biol Chem. 2009 Jul 31;284(31):20522-30. doi: 10.1074/jbc.M109.025346. Epub 2009 Jun 1.

    PMID: 19491109BACKGROUND
  • Arabi A, Ullah K, Branca RM, Johansson J, Bandarra D, Haneklaus M, Fu J, Aries I, Nilsson P, Den Boer ML, Pokrovskaja K, Grander D, Xiao G, Rocha S, Lehtio J, Sangfelt O. Proteomic screen reveals Fbw7 as a modulator of the NF-kappaB pathway. Nat Commun. 2012;3:976. doi: 10.1038/ncomms1975.

    PMID: 22864569BACKGROUND

MeSH Terms

Conditions

GingivitisPeriodontitisSmoking

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesBehavior

Study Officials

  • Kubra Aral, Phd

    Inonu University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 11, 2026

First Posted

August 14, 2026

Study Start

March 1, 2024

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

August 14, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be shared, including participant age, sex, and clinical periodontal parameters (plaque index, gingival index, probing depth, clinical attachment level, bleeding on probing). Participants will be identified only by coded/numbered case report forms; no names, gender identity beyond biological sex, or other identifying information will be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 6 months and ending 24 months following article publicatio
Access Criteria
Data will be made available to researchers who provide a methodologically sound proposal, subject to approval by the corresponding author, for the purpose of achieving the aims outlined in the approved proposal.

Locations